title: Growth hormone responses to pyridostigmine in normal adults and in normal and short children.
abstract: There is evidence indicating that the cholinergic system positively modulates GH release probably by inhibiting somatostatinergic tone. In the present study, the effects of cholinergic enhancement by pyridostigmine, (PD), a cholinesterases inhibitor, on GH release in normal adults (n = 14) (NA) and in both normal (n = 5) (NC) and short children (n = 19) (SC) with familial short stature (n = 7) or constitutional growth delay (n = 12) were studied. In SC the insulin hypoglycaemia (IH)-induced GH increase was also studied. In both NC and SC 60 mg orally PD induced a significant GH increase with mean peak at 90 min (mean +/- SEM 11.0 +/- 2.2 ng/ml in NC and 11.2 +/- 2.3 ng/ml in SC). The GH areas under response curve (AUC) were 379.3 +/- 76.6 and 327.8 +/- 43.2 ng/ml/h in NC and SC respectively. In NA 120 mg orally PD induced a significant GH increase with mean peak at 120 min (5.1 +/- 1.1 ng/ml) which was significantly lower (P less than 0.05) than that observed in both NC and SC. This statistical difference was strengthened by evaluating AUC (NA:205.6 +/- 33.7 ng/ml/h, P less than 0.05 vs NC and SC). The correlation of drug dosage with body area ruled out that this difference could be related to the different PD dose in adults and children. In SC, IH induced a GH increase significantly lower than that observed after PD (GH peak 7.8 +/- 0.6 vs 16.4 +/- 1.9 ng/ml P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Dipartimento di Biomedicina Endocrino-Metabolica e Gastroenterologica, Università di Torino, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Ghigo
authors.forename: E
authors.initials: E
authors.lastname: Mazza
authors.forename: E
authors.initials: E
authors.lastname: Imperiale
authors.forename: P
authors.initials: P
authors.lastname: Molinatti
authors.forename: A
authors.initials: A
authors.lastname: Bertagna
authors.forename: F
authors.initials: F
authors.lastname: Camanni
authors.forename: F
authors.initials: F
authors.lastname: Massara
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006130:Growth Disorders / Q000097:blood / Q000175:diagnosis / Q000503:physiopathology*; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D008297:Male; D011729:Pyridostigmine Bromide / Q000494:pharmacology*
chemical_list: D007328:Insulin; D013006:Growth Hormone; D011729:Pyridostigmine Bromide